title: Major tumor shrinking and persistent molecular remissions after consolidation with bortezomib, thalidomide, and dexamethasone in patients with autografted myeloma.
authors.affiliation: Cattedra di Ematologia, Via Genova 3, 10126 Torino, Italy. marco.ladetto@unito.it
authors.forename: Marco
authors.initials: M
authors.lastname: Ladetto
authors.forename: Gloria
authors.initials: G
authors.lastname: Pagliano
authors.forename: Simone
authors.initials: S
authors.lastname: Ferrero
authors.forename: Federica
authors.initials: F
authors.lastname: Cavallo
authors.forename: Daniela
authors.initials: D
authors.lastname: Drandi
authors.forename: Loredana
authors.initials: L
authors.lastname: Santo
authors.forename: Claudia
authors.initials: C
authors.lastname: Crippa
authors.forename: Luca
authors.initials: L
authors.lastname: De Rosa
authors.forename: Patrizia
authors.initials: P
authors.lastname: Pregno
authors.forename: Mariella
authors.initials: M
authors.lastname: Grasso
authors.forename: Anna Marina
authors.initials: AM
authors.lastname: Liberati
authors.forename: Tommaso
authors.initials: T
authors.lastname: Caravita
authors.forename: Francesco
authors.initials: F
authors.lastname: Pisani
authors.forename: Tommasina
authors.initials: T
authors.lastname: Guglielmelli
authors.forename: Vincenzo
authors.initials: V
authors.lastname: Callea
authors.forename: Pellegrino
authors.initials: P
authors.lastname: Musto
authors.forename: Clotilde
authors.initials: C
authors.lastname: Cangialosi
authors.forename: Roberto
authors.initials: R
authors.lastname: Passera
authors.forename: Mario
authors.initials: M
authors.lastname: Boccadoro
authors.forename: Antonio
authors.initials: A
authors.lastname: Palumbo
mesh_terms: D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D001897:Boronic Acids / Q000008:administration & dosage; D000069286:Bortezomib; D017024:Chemotherapy, Adjuvant; D016009:Chi-Square Distribution; D003907:Dexamethasone / Q000008:administration & dosage; D018572:Disease-Free Survival; D005260:Female; D015972:Gene Expression Regulation, Neoplastic; D015321:Gene Rearrangement; D050438:Genes, Immunoglobulin Heavy Chain; D006801:Humans; D007558:Italy; D053208:Kaplan-Meier Estimate; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000188:drug therapy* / Q000235:genetics / Q000473:pathology / Q000601:surgery*; D018365:Neoplasm, Residual; D016133:Polymerase Chain Reaction; D011719:Pyrazines / Q000008:administration & dosage; D033581:Stem Cell Transplantation; D013792:Thalidomide / Q000008:administration & dosage; D013997:Time Factors; D014182:Transplantation, Autologous; D016896:Treatment Outcome; D047368:Tumor Burden / Q000187:drug effects
chemical_list: D001897:Boronic Acids; D011719:Pyrazines; D013792:Thalidomide; D000069286:Bortezomib; D003907:Dexamethasone